Published in Psychopharmacology (Berl) on April 05, 2013
Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects. Ther Adv Drug Saf (2014) 0.78
Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy. PLoS One (2015) 0.75
Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis. PLoS One (2015) 0.75
Recent advances in understanding maternal perinatal mood disorders. F1000Res (2017) 0.75
A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg (1954) 10.68
Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA (2010) 4.33
Cost of relapse in schizophrenia. Schizophr Bull (1995) 3.04
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00
Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry (2008) 1.74
The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry (2002) 1.68
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry (2009) 1.53
Measuring outcomes after extreme prematurity with the Bayley-III Scales of infant and toddler development: a cautionary tale from Australia. Arch Pediatr Adolesc Med (2010) 1.29
Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. Psychopharmacology (Berl) (2006) 1.19
Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry (2007) 1.07
Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 1.06
The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.03
Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res (2010) 1.02
Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry (2012) 0.92
Application of the Flynn effect for the Bayley III Scales. Arch Pediatr Adolesc Med (2010) 0.90
Atypical antipsychotic use in pregnancy: a retrospective review. Arch Womens Ment Health (2009) 0.87
Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress. Neurosci Res (2011) 0.87
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.84
Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. J Neuropsychiatry Clin Neurosci (2007) 0.82
Safety of clozapine in 2 successive pregnancies. Can J Psychiatry (2004) 0.81
Clozapine use in two women with schizophrenia during pregnancy. J Psychopharmacol (2008) 0.79
The fate of drugs in pregnancy. Clin Obstet Gynaecol (1986) 0.79
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
Screening for bipolar disorder in the community. J Clin Psychiatry (2003) 4.24
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol (2006) 3.77
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry (2013) 2.80
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry (2006) 2.19
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry (2006) 2.17
Validity of the mood disorder questionnaire: a general population study. Am J Psychiatry (2003) 2.10
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry (2002) 2.01
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry (2009) 1.96
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study. Arch Gen Psychiatry (2010) 1.89
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry (2007) 1.88
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry (2004) 1.86
Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry (2012) 1.85
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry (2003) 1.84
Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry (2014) 1.78
A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry (2006) 1.68
Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry (2005) 1.64
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord (2009) 1.60
Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry (2009) 1.59
Gender differences in criminality: bipolar disorder with co-occurring substance abuse. J Am Acad Psychiatry Law (2005) 1.59
Developing a 10-item mania scale from the Parent General Behavior Inventory for children and adolescents. J Clin Psychiatry (2008) 1.58
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry (2005) 1.56
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.56
Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings. Bipolar Disord (2005) 1.56
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry (2005) 1.53
Toward an evidence-based assessment of pediatric bipolar disorder. J Clin Child Adolesc Psychol (2005) 1.50
Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 years. J Am Acad Child Adolesc Psychiatry (2004) 1.48
Discriminative validity of a parent version of the Young Mania Rating Scale. J Am Acad Child Adolesc Psychiatry (2002) 1.48
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Br J Psychiatry (2004) 1.46
Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psychiatry (2015) 1.44
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry (2004) 1.44
Cytogenetic distinction among benign fibro-osseous lesions of bone in children and adolescents: value of karyotypic findings in differential diagnosis. Pediatr Dev Pathol (2004) 1.43
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry (2016) 1.43
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Recent placebo-controlled acute trials in bipolar depression: focus on methodology. Int J Neuropsychopharmacol (2003) 1.38
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry (2007) 1.34
Validation of the Italian version of the "Mood Disorder Questionnaire" for the screening of bipolar disorders. Clin Pract Epidemiol Ment Health (2005) 1.29
Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry (2005) 1.28
Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years. J Clin Child Adolesc Psychol (2002) 1.26
Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans. PLoS One (2012) 1.24
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry (2006) 1.24
Who are the comorbid adolescents? Agreement between psychiatric diagnosis, youth, parent, and teacher report. J Abnorm Child Psychol (2003) 1.23
Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord (2010) 1.21
Early symptoms of mania and the role of parental risk. Bipolar Disord (2005) 1.20
Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol (2008) 1.19
Employing parent, teacher, and youth self-report checklists in identifying pediatric bipolar spectrum disorders: an examination of diagnostic accuracy and clinical utility. J Child Adolesc Psychopharmacol (2003) 1.18
Atypical antipsychotics in bipolar depression: potential mechanisms of action. J Clin Psychiatry (2005) 1.17
Abnormal regional spontaneous neural activity in first-episode, treatment-naive patients with late-life depression: a resting-state fMRI study. Prog Neuropsychopharmacol Biol Psychiatry (2012) 1.16
Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. J Clin Psychiatry (2007) 1.13
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry (2004) 1.13
Effects of adolescent manic symptoms on agreement between youth, parent, and teacher ratings of behavior problems. J Affect Disord (2004) 1.13
Bipolar depression: overview and commentary. Harv Rev Psychiatry (2010) 1.12
Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology (2002) 1.10
Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum. Infect Immun (2013) 1.10
Abnormal amplitude low-frequency oscillations in medication-naive, first-episode patients with major depressive disorder: a resting-state fMRI study. J Affect Disord (2012) 1.09
Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J Clin Psychiatry (2006) 1.07
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. Clin Trials (2009) 1.06
Coincident posttraumatic stress disorder and depression predict alcohol abuse during and after deployment among Army National Guard soldiers. Drug Alcohol Depend (2012) 1.06
The empirical redefinition of the psychometric criteria for remission in bipolar disorder. J Affect Disord (2007) 1.04
Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics? J Affect Disord (2008) 1.02
Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Aust N Z J Psychiatry (2005) 1.01
Sex differences in pediatric bipolar disorder. J Clin Psychiatry (2007) 1.01
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol (2004) 1.01
Medical and substance use comorbidity in bipolar disorder. J Affect Disord (2008) 1.00
Abnormal resting-state cerebellar-cerebral functional connectivity in treatment-resistant depression and treatment sensitive depression. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.99
Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. J Affect Disord (2011) 0.98
Comparing the effects of sampling designs on the diagnostic accuracy of eight promising screening algorithms for pediatric bipolar disorder. Biol Psychiatry (2006) 0.97
Typical and atypical antipsychotics in bipolar depression. J Clin Psychiatry (2005) 0.96
Second-generation antipsychotics in major depressive disorder: update and clinical perspective. Curr Opin Psychiatry (2011) 0.96
Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension. J Clin Psychopharmacol (2012) 0.96
Discriminative validity of the general behavior inventory using youth report. J Abnorm Child Psychol (2003) 0.96
Altered white matter integrity of forebrain in treatment-resistant depression: a diffusion tensor imaging study with tract-based spatial statistics. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.95
Use of health care services among persons who screen positive for bipolar disorder. Psychiatr Serv (2005) 0.95
The lifetime prevalence of bipolar disorders and the use of antidepressant drugs in bipolar depression in Italy. J Affect Disord (2011) 0.95
The role of family functioning in bipolar disorder in families. J Abnorm Child Psychol (2008) 0.95
Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics. J Clin Psychiatry (2010) 0.95
Resting-state functional connectivity bias of middle temporal gyrus and caudate with altered gray matter volume in major depression. PLoS One (2012) 0.94
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry (2002) 0.94
A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. J Clin Psychiatry (2008) 0.93
Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry (2003) 0.93
Significant linkage and association between a functional (GT)n polymorphism in promoter of the N-methyl-D-aspartate receptor subunit gene (GRIN2A) and schizophrenia. Neurosci Lett (2006) 0.93
Posttraumatic stress disorder, depression, and HIV risk behavior among Ohio Army National Guard Soldiers. J Trauma Stress (2013) 0.93
Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol (2007) 0.93
Adherence to pharmacological treatment for juvenile bipolar disorder. J Am Acad Child Adolesc Psychiatry (2007) 0.92
Altered white matter integrity in young adults with first-episode, treatment-naive, and treatment-responsive depression. Neurosci Lett (2012) 0.92
Prefrontal activation during verbal fluency tests in schizophrenia--a near-infrared spectroscopy (NIRS) study. Schizophr Res (2005) 0.92